IMBRUVICA ibrutinib 280 mg film-coated tablet blister

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 48882db1bf7cccc6
Product Name: IMBRUVICA ibrutinib 280 mg film-coated tablet blister
Artg Id: 319357
Artg Name: IMBRUVICA ibrutinib 280 mg film-coated tablet blister
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2020-08-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01679-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01676-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

48882db1bf7cccc6

Type

Standard